JMS Co

JMS Co Operating Expenses

The Total Operating Expenses of JMS Co (7702.T) as of Nov 2, 2026 is 11.02 B JPY. In the previous year, Total Operating Expenses was 12.13 B JPY — a change of -9.14% (lower).

Operating Expenses

11.02 BJPY

YoY

-9.14%

Last updated:

Total Operating Expenses of JMS Co is 2025 11.02 B JPY. Total Operating Expenses of JMS Co was 2024 12.13 B JPY. It decreases by -9.14% lower compared to the previous year.

The JMS Co Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
11.75 B JPY
Jan 1, 2019
11.37 B JPY
Jan 1, 2020
11.26 B JPY
Jan 1, 2021
10.88 B JPY
Jan 1, 2022
11.03 B JPY
Jan 1, 2023
11.41 B JPY
Jan 1, 2024
12.13 B JPY
Jan 1, 2025
11.02 B JPY
The JMS Co Operating Expenses history
YEAROperating ExpensesYoY
11.02 BJPY-9.14%
12.13 BJPY+6.24%
11.41 BJPY+3.52%
11.03 BJPY+1.33%
10.88 BJPY-3.33%
11.26 BJPY-0.99%
11.37 BJPY-3.23%
11.75 BJPY+3.31%
11.37 BJPY-0.12%
11.39 BJPY+2.91%
11.06 BJPY+3.42%
10.70 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Total Operating Expenses of JMS Co is 11.02 B JPY in 2025.

Total Operating Expenses of JMS Co changed from 12.13 B JPY to 11.02 B JPY, representing a -9.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses JMS Co since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's JMS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — JMS Co

All Key Metrics — JMS Co